Related Experiment Videos
Using Cell Lines To Guide Neoadjuvant Therapy in Bladder Cancer: COXEN and SWOG S1314
Garrett M Dancik1, Dan Theodorescu2
1Department of Computer Science, Eastern Connecticut State University, Willimantic, CT, USA.
European Urology Focus
|March 27, 2022
Abstract:
There are no predictive biomarkers in clinical use for the neoadjuvant treatment of bladder cancer. Here we report on a recent randomized phase 2 trial validating the identification of predictive biomarkers using cell lines in the absence of patient response data.